Berapakah harga AlloVir, Inc. (ALVR)

Harga AlloVir, Inc. (ALVR) adalah $9.81

Apakah topi pasaran AlloVir, Inc. (ALVR)

Cap pasaran AlloVir, Inc. (ALVR) adalah $48.68M

AlloVir, Inc. (ALVR) EPS

AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.

Tahun	EPS	Ubah
2026 (TTM)	$-1.71	-85.42%
2024	$-11.73	-72.13%
2023	$-42.09	-16.82%
2022	$-50.60	-19.71%
2021	$-63.02	5.79%
2020	$-59.57	354.39%
2019	$-13.11	71,150.00%
2018	$-0.02	0.00%

Tahun

EPS

Ubah

2026 (TTM)

$-1.71

-85.42%

2024

$-11.73

-72.13%

2023

$-42.09

-16.82%

2022

$-50.60

-19.71%

2021

$-63.02

5.79%

2020

$-59.57

354.39%

2019

$-13.11

71,150.00%

2018

$-0.02

0.00%

Syarikat	EPS	Perbezaan EPS	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-1,112.87%	US
Argenx SE ARGX.US	$27.74	-1,722.22%	NL
CSL Limited CSL.AX	$2.98	-274.27%	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	$-7.98	366.67%	US

Syarikat

EPS

Perbezaan EPS

Negara